Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Do you honestly think

<< Previous

Bullboard Posts

Next >>

Post by Red~Oneon Oct 16, 2021 10:47pm

304 Views

Post# 34014397

Do you honestly think

Do you honestly think that your words here are affecting the shareprice, you are so desperate to protect your bloated position that you have become patheticly desperate and it shows. Personal attacks.

You would be better off to stay silent and wait and see what happens next week or next year. The truth will be clear as day, it already is if you look.

<< Previous

Bullboard Posts

Next >>

Cross border trading in Canada and Australia